Filing Flows › Opko Health (OPK) › Recalls, complaints & regulation
Opko Health (OPK): clinical trials
Opko Health (OPK) beyond its filings: 2 active clinical trials.
Opko Health's latest quarter
Opko Health, Q3 2026: revenue $65.4M (+16% year over year), operating margin -48.0%, net loss $53.5M, operating cash flow −$36.3M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Opko Health have?
2 active studies on ClinicalTrials.gov, 0 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.